Federal Circuit blocks Sandoz generic

30-08-2019

Rory O'Neill

Federal Circuit blocks Sandoz generic

IgorGolovniov / Shutterstock.com

The US Court of Appeals for the Federal Circuit has ruled that claims in an Allergan patent detailing the results of a glaucoma treatment are material to its patentability, after an unsuccessful invalidation appeal brought by Sandoz.


Sandoz, Allergan, glaucoma, Combigan, limiting

LSIPR